Related Experiment Video
Updated: Jan 24, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
LNK suppresses interferon signaling in melanoma
Ling-Wen Ding1, Qiao-Yang Sun2, Jarem J Edwards3,4
1Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
Abstract:
LNK (SH2B3) is a key negative regulator of JAK-STAT signaling which has been extensively studied in malignant hematopoietic diseases. We found that LNK is significantly elevated in cutaneous melanoma; this elevation is correlated with hyperactive signaling of the RAS-RAF-MEK pathway. Elevated LNK enhances cell growth and survival in adverse conditions. Forced expression of LNK inhibits signaling by interferon-STAT1 and suppresses interferon (IFN) induced cell cycle arrest and cell apoptosis. In contrast, silencing LNK expression by either shRNA or CRISPR-Cas9 potentiates the killing effect of IFN. The IFN-LNK signaling is tightly regulated by a negative feedback mechanism; melanoma cells exposed to IFN upregulate expression of LNK to prevent overactivation of this signaling pathway. Our study reveals an unappreciated function of LNK in melanoma and highlights the critical role of the IFN-STAT1-LNK signaling axis in this potentially devastating disease. LNK may be further explored as a potential therapeutic target for melanoma immunotherapy.
Insights
Lymphoid Nuclear protein (LNK) is elevated in melanoma, promoting cancer cell growth. Silencing LNK enhances interferon
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- LNK (SH2B3) is a known regulator of JAK-STAT signaling, primarily studied in blood cancers.
- Its role in solid tumors like cutaneous melanoma is largely uncharacterized.
Purpose of the Study:
- To investigate the function of LNK in cutaneous melanoma.
- To elucidate the relationship between LNK, RAS-RAF-MEK signaling, and interferon (IFN) response in melanoma.
Main Methods:
- Analysis of LNK expression in melanoma tissues.
- Investigating the impact of LNK modulation (overexpression, shRNA, CRISPR-Cas9) on melanoma cell signaling pathways (JAK-STAT, RAS-RAF-MEK, IFN-STAT1).
- Assessing the effects of LNK on cell growth, survival, cell cycle arrest, and apoptosis, particularly in response to IFN treatment.
Main Results:
- LNK is significantly elevated in cutaneous melanoma.
- Elevated LNK correlates with hyperactive RAS-RAF-MEK signaling and promotes melanoma cell growth and survival.
- LNK negatively regulates IFN-STAT1 signaling, suppressing IFN-induced cell cycle arrest and apoptosis.
- Silencing LNK potentiates the anti-melanoma effects of IFN.
- Melanoma cells upregulate LNK in response to IFN, indicating a negative feedback loop.
Conclusions:
- LNK plays a critical, previously unappreciated role in melanoma pathogenesis.
- The IFN-STAT1-LNK signaling axis is a key regulator in melanoma.
- LNK represents a potential therapeutic target for enhancing melanoma immunotherapy.
Related Concept Videos
What is Cell Signaling?
Paracrine Signaling
Endocrine Signaling
Synaptic Signaling
Bacterial Signaling
Yeast Signaling

